Patents for Restasis Are Invalidated, Opening Door to Generics – New York Times

Patents for Restasis Are Invalidated, Opening Door to Generics
New York Times
Four patents for the dry-eye treatment Restasis were invalidated by a federal judge on Monday. Allergan, the drug's manufacturer, had sought to protect the patents by transferring them to a Native American tribe in New York State. Credit Martin Shields …
Judge throws out Allergan patent, slams company's Native American dealArs Technica
Mylan Invalidates Allergan's Patents on Restasis®PR Newswire (press release)
Federal judge invalidates Restasis patents in blow to AllerganBioPharma Dive
MarketWatch –Seeking Alpha –Wall Street Journal –Nasdaq
all 40 news articles »